> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 2021 Drug Safety Priorities Report
- URL: https://www.fdaweb.com/2021-drug-safety-priorities-report/
- Published: 2022-02-01T12:00:00.000Z
- Updated: 2026-09-14T17:30:51.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5151048

FDA has issued its 2021 Drug Safety Priorities report detailing CDER safety programs and activities and “highlighting the depth and versatility of drug safety initiatives across CDER and FDA.” The [report](https://www.fda.gov/drugs/drug-safety-and-availability/advances-fdas-drug-safety-programs?utm%5Fmedium=email&utm%5Fsource=govdelivery) is said to explain CDER’s efforts to manage drug safety through modernized safety surveillance methods and innovative responses to safety concerns.

Links to six previous reports also are available at the site of the 2021 report.